MedTrace Logo

POA Retrospective Repository

NCT03326479 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2017-10-31

No results posted yet for this study

Summary

This repository is a multi-center, outcomes study designed to retrospectively collect data on the demographics, presentation, diagnosis, treatment, cost of associated care, quality of life, and outcomes of subjects utilizing Caris Molecular Intelligence® (CMI) Services for the treatment of cancer. Prior to enrolling a subject, the subject's physician will have made the independent decision whether or not to utilize the drug associations provided by CMI and made clinical treatment choices as appropriate. Thus, data captured and reported provides a "real world" perspective on diagnosis, treatment, cost, and outcomes.

Conditions

Interventions

DIAGNOSTIC_TEST

Caris Molecular Intelligence Profile

A comprehensive biomarker testing

Sponsors & Collaborators

  • Caris Science, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2023-01-01
Completion
2023-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03326479 on ClinicalTrials.gov